This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stock Futures Point to Lower Open

The Philadelphia Federal Reserve's business outlook survey, out at 10 a.m. as well, is expected to show an improvement to minus 3 for December from minus 10.7 in November.

Simultaneously, the Conference Board's Leading Economic Indicators Index is predicted to have declined to minus 0.2% in November after increasing 0.2% in October.

Also out at 10 a.m. is the Federal Housing Finance Agency's housing price index for October.

The FTSE 100 in London was up 0.06% and the DAX in Germany was lower by 0.03% after major European indices soared to fresh 2012 highs the prior session.

The Asian markets finished mixed as the amount by which the Bank of Japan expanded its asset-buying program fell short of some investors' expectations. Hong Kong's Hang Seng index closed up by 0.16% and Japan's Nikkei average finished off 1.19% Thursday.

Gold for February delivery was up 50 cents at $1,668.20 an ounce at the Comex division of the New York Mercantile Exchange, while February crude oil contracts were down 10 cents at $89.88 a barrel.

The benchmark 10-year Treasury was rising 9/32, diluting the yield to 1.775%. The dollar was off 0.06%, according to the U.S. dollar index.

In corporate news, NYSE Euronext (NYX), the operator of the New York Stock Exchange, announced that it has agreed to be bought by rival IntercontinentalExchange (ICE) for $33.12 a share in stock and cash, or a total of about $8.2 billion.

IntercontinentalExchange shares were tumbling more than 4% in premarket trading Thursday while NYSE Euronext shares were not yet active.

Bed Bath & Beyond (BBBY) on Wednesday issued forecasts for the fourth quarter and fiscal year that were below analysts' views.

Shares were shedding 5%.

Jabil Circuit (JBL) posted fiscal first-quarter earnings on Wednesday that topped Wall Street estimates.

Shares were jumping more than 4.5%.

An experimental therapy from Amicus Therapeutics (FOLD) and GlaxoSmithKline (GSK) failed to improve kidney response in Fabry disease patients compared to placebo in a late-stage study, the companies disclosed late Wednesday.

Amicus shares were plunging by more than 43.5%.

ConAgra Foods (CAG) posted second-quarter earnings of 57 cents a share on revenue of $3.74 billion, beating the average analyst estimate of 55 cents a share on revenue of $3.69 billion, on robust sales from its consumer foods business.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,915.07 -70.54 -0.42%
S&P 500 1,964.68 -8.15 -0.41%
NASDAQ 4,396.2040 -22.83 -0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs